|
Home : Unsafe Drugs : Avandia : News Articles : Glaxo posts Q4 loss on Avandia charge - Forbes.com Glaxo posts Q4 loss on Avandia charge - Forbes.com
drug maker by revenue, has posted a fourth-quarter loss after taking a massive charge to provide for US litigation over its diabetes drug, Avandia. Glaxo on Thursday posted a net loss of 690 million pounds ($1.12 billion) for the three months to Dec. ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




